Explore how neoantigens and tumor mutations are transforming multiple myeloma treatment through personalized immunotherapy approaches.
Discover how scientists are targeting Treg cell metabolism to break cancer's immune defenses and revolutionize immunotherapy treatments.
Discover how PCBP1-AS1 regulates Treg infiltration and serves as a potential biomarker for immunotherapy response in lung adenocarcinoma.
Breakthrough in DNA vaccine for early-stage Waldenström macroglobulinemia shows promising results in clinical trials
Discover how galectin-1 overexpression in Hodgkin lymphoma creates an immunosuppressive microenvironment and the promising therapeutic strategies targeting this mechanism.
The revolutionary science behind ETS inhibitors and their powerful synergy with immunotherapy in fighting treatment-resistant blood cancers